China Story

<div class='circular--portrait' style='background:#FF6600;color: #FFFAFA;font-size:4em;'>CB</div>
CBPO -- USA Stock  

USD 113.18  0.31  0.27%

China Stock News module provides quick insight into current market opportunities from investing in China Biologic Products. Use historical and current headlines to determine the investment entry and exit points. Many technical investors use China Biologic Products stock news signals to limit their universe of possible portfolio assets and to time the market correctly. Continue to China Biologic Hype Analysis, China Biologic Correlation and China Biologic Performance.

Search Today's Stock News

 
Refresh
China Biologic stock news, alerts, and headlines are usually related to their technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of China daily returns and investor perception about the current pice of China Biologic Products as well as its diversification or hedging effects on your existing portfolios.
Exercise or conversion by Kuo Yuyun Tristan of 5000 shares of China Biologic subject to Rule 16b-3
Filed transaction by China Biologic Products H officer. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

China Biologic Products insider trading alert for exercise of non-qualified stock option (right to buy) by Kuo Yuyun Tristan, CFO, on 15th of June 2020. This event was filed by China Biologic Products H with SEC on 2011-12-14. Statement of changes in beneficial ownership - SEC Form 4

Cash Floor Correlation

Click cells to compare fundamentals   

Cash per Share

Cash per Share Comparative Analysis

China Biologic is currently under evaluation in cash per share category among related companies. Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.

Peers

China Biologic Related Equities

NKNantKwest   6.85   
0%
100.0%
DYAIDYADIC INTERNATIONAL INC   4.44   
0%
64.0%
DMACDiaMedica Therapeutics   2.38   
0%
34.0%
DTILPrecision BioSciences   1.90   
0%
27.0%
EDITEditas Medicine   1.55   
0%
22.0%
DNLIDenali Therapeutics   0.54   
0%
7.0%
EQEquillium   0.52   
0%
7.0%
DVAXDynavax Technologies Corporation   0.95   
13.0%
0%
DRNADicerna Pharmaceuticals   1.42   
20.0%
0%
EARSAuris Medical Holding   3.33   
48.0%
0%
Continue to China Biologic Hype Analysis, China Biologic Correlation and China Biologic Performance. Please also try Stock Screener module to find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..